The clinical study of pitavastatin treatment for group of mild to moderate alzheimer's disease (PIT-ROAD).

Trial Profile

The clinical study of pitavastatin treatment for group of mild to moderate alzheimer's disease (PIT-ROAD).

Discontinued
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2012

At a glance

  • Drugs Cholesterol inhibitors; Pitavastatin
  • Indications Alzheimer's disease; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms PIT-ROAD
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Jun 2012 Actual patient number is 38 according to ClinicalTrials.gov.
    • 13 Jun 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top